CIK 0001604821 · Large accelerated filer
Natera, Inc.
Sign in to watch- Ticker
- NTRA
- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 010894487
- Phone
- 650-249-9090
- Business address
- 13011 MCCALLEN PASS, BUILDING A SUITE 100, AUSTIN, TX, 78753
- Former names
- Natera, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $104,832,418
- in 28 filings, $104.8M under 10b5-1 plans
Net −$104,832,418. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Rabinowitz Matthew −$72.3M EXECUTIVE CHAIRMAN sold 9% of stake
- Sheena Jonathan −$13.8M Director sold 83% of stake
- Moshkevich Solomon −$9.5M PRESIDENT, CLINICALDIAGNOSTICS sold 21% of stake
- Chapman Steven Leonard −$5.0M CEO AND PRESIDENT sold 12% of stake
- Brophy Michael Burkes −$2.5M CHIEF FINANCIAL OFFICER sold 11% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-01-14 | RABINOWITZ DANIEL SEC. AND CHIEF LEGAL OFFICER | Grant or award 10b5-1 | +37,248 | 245,849 | ||
| 2026-01-14 | Chapman Steven Leonard CEO AND PRESIDENT | Grant or award 10b5-1 | +152,718 | 289,286 | ||
| 2026-01-14 | Brophy Michael Burkes CHIEF FINANCIAL OFFICER | Grant or award 10b5-1 | +59,596 | 123,722 | ||
| 2026-01-14 | Sheena Jonathan Director | Grant or award 10b5-1 | +7,450 | 270,031 | ||
| 2026-01-05 | Sheena Jonathan Director | Option exercise | +39,615 | $9.59 | $380K | 262,581 |
| 2026-01-05 | Sheena Jonathan Director | Option exercise · Stock Option (right to buy) | −39,615 | 0 | ||
| 2026-01-02 | Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS | Sale 10b5-1 | −1,292 | $228.33 | $295K | 125,158 |
| 2026-01-02 | Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS | Sale 10b5-1 | −1,659 | $229.43 | $381K | 123,499 |
| 2026-01-02 | Chapman Steven Leonard CEO AND PRESIDENT | Sale 10b5-1 | −2,214 | $228.64 | $506K | 138,202 |
| 2026-01-02 | Chapman Steven Leonard CEO AND PRESIDENT | Sale 10b5-1 | −1,634 | $229.67 | $375K | 136,568 |
| 2025-12-19 | Sheena Jonathan Director | Sale 10b5-1 | −200 | $224.89 | $45K | 23,082 |
| 2025-12-19 | Sheena Jonathan Director | Sale 10b5-1 | −550 | $226.36 | $124K | 22,532 |
| 2025-12-19 | Sheena Jonathan Director | Sale 10b5-1 | −200 | $224.74 | $45K | 23,082 |
| 2025-12-19 | Sheena Jonathan Director | Sale 10b5-1 | −550 | $226.34 | $124K | 22,532 |
| 2025-12-17 | Sheena Jonathan Director | Sale 10b5-1 | −1,592 | $226.54 | $361K | 224,444 |
| 2025-12-17 | Sheena Jonathan Director | Sale 10b5-1 | −1,348 | $227.44 | $307K | 223,096 |
| 2025-12-17 | Sheena Jonathan Director | Sale 10b5-1 | −130 | $228.28 | $30K | 222,966 |
| 2025-12-15 | Sheena Jonathan Director | Gift 10b5-1 | −1,060 | 226,036 | ||
| 2025-12-15 | Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS | Gift | −115 | 126,450 | ||
| 2025-12-12 | Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS | Gift | −180 | 108,881 |
Page 30 of 39 · 767 trades